Impact fact

Shabnam is an expert in cell and gene therapies commercialization issues. She has worked with several clients in this domain across a variety of therapeutic areas.


Shabnam is an associate principal within the Princeton office, focusing on the strategic planning in the cell and gene therapy commercialization area.


As a leader in cell and gene therapy, Shabnam has helped several companies with launch strategy. She has led multiple strategic planning exercises across different therapeutic areas.

Prior experience

Shabnam has been working at ZS since 2011. Prior to joining ZS, Shabnam worked within business analytics for pharma clients in Bengaluru, India.


Shabnam holds an MBA from National Institute of Pharmaceutical Education and Research and a bachelor’s degree in pharmaceutical sciences from Kurukshetra University.